Elbow Beach Capital has backed bioelectronics startup QV Bioelectronics in a Pre-Series A round led by Science Angel Syndicate and Fink Family Office. Based in Manchester, QV Bioelectronics has created an innovative surgically implanted Electric Field Therapy (EFT) device for the treatment of brain tumours.
Elbow Beach Capital has invested in chemistry automation startup, CheMastery in a seed round led by Science Angel Syndicate and Undeterred Capital. Founded by Dr Anna Andreou and Dr Stefan Glatzel, CheMastery aims to revolutionise the way in which chemical research and manufacturing are carried out.
Elbow Beach Capital investee, Munro Vehicles last night unveiled its first all-electric off-roader, the MK_1. It is the first light vehicle to enter production in Scotland in more than four decades and its unique attributes make it an ideal low-carbon choice for sectors such as construction, agriculture, forestry and mining.
Elbow Beach Capital is pleased to announce that Andy Summerfield has been appointed as an Investment Director of the company. Andy, a founding member of EBC’s advisory board has significant expertise in go-to-market strategy and organisational transformation.
The World’s First Needle-Free Continuous Glucose Monitor
21 September 2022
Elbow Beach Capital has invested in MedTech pioneers, Transdermal Diagnostics. TD is a University of Bath MedTech spin-out dedicated to developing and commercialising innovative technologies for needle-less monitoring of health biomarkers in real-time.
Elbow Beach Capital Leads Seed Round into Anaphite
26 August 2022
Elbow Beach Capital announces a £1.5m investment into graphene technology innovators, Anaphite leading a £4.1m seed round supported by Wealth Club, Blue Wire Capital, Zero Carbon Capital, OION, Silicon Roundabout Ventures and Deeptech Labs.
A Climate of Adventure: Why VC Needs to Rediscover Risk
25 July 2022
EBC Opinion: Investment in UK ClimateTech is at an all-time high with over £2Bn raised by domestic startups last year. However, early-stage investment, particularly into climate hardware, still lags significantly behind the venture safe havens of SaaS and FinTech.
Elbow Beach Capital Backs Biomaterial Innovators Zentraxa
20 June 2022
Elbow Beach Capital backs biomaterial innovators, Zentraxa. Biomaterials can fundamentally alter the performance of everyday products. The difficulty is finding methods that allow you to make these biomaterials at sufficient scale.
